BioWell provides a doctor led metabolic management plan. Medication may form part of a plan where clinically indicated. Patients are not buying a pen from a website, but rather a programme. If medication is prescribed, it is dispensed from a licensed dispensing practitioner or pharmacy.

No. BioWell builds a structured plan around assessment, nutrition, training guidance, and monitoring. Medication is introduced only where a doctor determines it is appropriate.

Programme length varies by patient, goals, and clinical response. BioWell treats it as a goal based plan with tapering or stopping once targets are reached, not an open ended medicine service.

No. BioWell operates on a medical model with consultation, prescription where appropriate, and ongoing clinical review rather than a retail subscription.

BioWell runs as a formal online medical practice with verified consultations, doctor controlled prescribing, documented clinical decisions, licensed pharmacy dispensing, and controlled cold chain delivery where required. Should the need arise, in person consultation will be suggested.

BioWell does not force a single template. A clinician sets nutrition structure and exercise guidance suited to the patient, with an emphasis on metabolic fat burning heart rate zone cardio, resistance training and sustainable routines.

Weight regain is possible if appetite control, habits, and metabolic drivers are not addressed. BioWell plans for tapering and a maintenance phase, with lifestyle structure and follow up designed to protect long term outcomes.

Not always, but blood work may be required depending on history and risk profile. Existing recent results can be reviewed, and additional baseline tests may be requested where clinically necessary.

Follow ups are structured with weekly feedback sessions on the platform and direct communication with your doctor and scheduled based on clinical need. Prescriptions are reviewed monthly, with additional check ins as indicated by response and safety considerations.

Yes. BioWell is built for online access and can support patients across South Africa, with delivery logistics structured for cold chain handling where required.

Most patients can be managed fully online. In person assessment may be recommended if a clinician identifies risks, unclear symptoms, or a need for physical examination.

Patients qualify based on clinical screening and medical rationale, not demand or ability to pay. A doctor assesses metabolic risk, contraindications, and treatment goals before prescribing.

Exclusions and cautions are determined case by case. Common examples include pregnancy or breastfeeding, certain endocrine tumour risks (such as medullary thyroid carcinoma/MEN2 risk profiles), uncontrolled severe gastrointestinal disease, and other conditions where a clinician determines risk outweighs benefit.

Patients may also be guided toward alternative treatment pathways where psychological or emotional factors indicate that pharmaceutical support may not be appropriate, at the doctor’s discretion.

A clinician reviews all current medication for interactions and risk. Treatment is adjusted or declined where safety cannot be assured.

Prescription based metabolic therapy medicines mimic gut hormone pathways that influence appetite regulation, blood sugar control, and gastric emptying. They can support structured metabolic care when prescribed and monitored appropriately.

Some prescription based metabolic therapy medicines are registered in South Africa for specific indications, and the regulatory position may differ depending on the molecule and its approved use.

BioWell’s doctors can prescribe compounded medicines that are individually prepared by licensed compounding pharmacies for a specific patient on a doctor’s prescription, rather than supplied as fixed, mass-manufactured commercial products. The practice operates strictly within SAHPRA and HPCSA requirements under a formal medical framework.

Compounded medicines are not specifically tested and registered by SAHPRA for safety and efficacy but when the specific medications are registered for clinical use and prepared by licensed compounding pharmacies operating under regulated pharmacy practice standards, using legally sourced active pharmaceutical ingredients, with patient-specific prescriptions and traceable dispensing, medication is safely prescribed by your doctor. BioWell relies on that controlled framework rather than informal supply channels.

Prescription based metabolic therapy medicines are not typically associated with classic “overdose” patterns in the way some medicines are, but taking more than prescribed can increase adverse effects and risk. Keeping in mind that side effects and complications can occur even when following dosing guidelines etc. BioWell reduces risk through conservative dosing ranges, patient education, and structured monitoring.

Dose escalation is clinician-led, based on response and tolerability. BioWell does not increase dosing purely on patient preference where clinical indicators do not support it.

Monthly validity supports clinical governance. It requires review before continuation, keeps dosing controlled, and reduces the risk of unsupervised long-term use without medical oversight.

Muscle loss can occur with rapid weight loss, especially without resistance training and sufficient protein intake. BioWell supports lean-mass preservation through structured exercise guidance and nutritional structure, with monitoring to keep loss gradual and clinically appropriate.

BioWell’s low dosage and specific compounded formulations assist in keeping muscle loss to a minimum.

Metabolic adaptation can occur with weight loss in general. BioWell manages this risk through gradual loss targets, resistance training guidance, and structured monitoring rather than aggressive calorie restriction or high-dose protocols.

They are not considered addictive in the way substances of dependence are. They can, however, become psychologically relied on if used without defined endpoints and a maintenance plan, which is why BioWell treats them as time-bound support within a structured programme.

Used correctly, they function as clinical tools to support metabolic regulation within a structured programme that still requires nutrition structure, movement, and follow-up.

Yes. BioWell relies on licensed compounding pharmacies operating under regulated pharmacy practice standards and applicable SAHPRA-related requirements.

Medication is compounded through licensed facilities, not informal settings. Dispensing occurs against patient-specific prescriptions within controlled pharmacy systems.

BioWell utilises logistics providers that use refrigerated, controlled delivery processes where required to protect product integrity in transit.

Yes. Prescriptions are issued per patient, with documented clinical rationale and controlled dispensing.

Prescriptions are doctor-controlled, time-bound, and reviewed through structured follow-up. Adjustments and renewals occur through clinical review rather than automatic repeats.

BioWell operates within South African medical and pharmacy standards, with consultation-based prescribing, controlled dispensing, and adherence to professional advertising and communication rules.

Yes. BioWell’s clinical care is delivered by qualified, registered practitioners working within a formal medical practice framework.

South African rules restrict direct-to-consumer advertising of compounded prescription medicines and related pricing in ways that can be interpreted as marketing a medicine to the public. BioWell keeps public communication focused on the medical programme and consultation process.

The consultation fee covers clinical review, assessment, and treatment planning within a formal medical framework. It is the entry point for medical decision-making.

Ongoing costs depend on the need for in person follow-up requirement, required investigations, and whether prescription therapy forms part of the plan. BioWell explains cost structure during consultation based on the patient’s pathway.

BioWell aims for transparency. Fees are communicated as part of the clinical process and should be understood before proceeding.

BioWell and Dr GL Vosloo does not claim from medical aids directly for the services rendered. Coverage varies by scheme, benefit option, diagnosis, and coding. Patients should confirm directly with their medical aid whether submission for consultation and or medications can be done, BioWell can provide supporting documentation where appropriate.